Medpace Holdings (MEDP) Operating Income Growth (3y) (2018 - 2026)
Medpace Holdings (MEDP) Operating Income Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 9.77% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | -1.04% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 12.85% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 1.37% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -1.16% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 12.23% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 68.50% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 3.10% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 9.67% |
| 10 | Medpace Holdings | 16.54 Bn | 16.03 Bn | 201.64 Mn | 23.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23.27% |
| Mar 31, 2026 | 17.96% |
| Dec 31, 2025 | 26.10% |
| Sep 30, 2025 | 22.14% |
| Jun 30, 2025 | 28.00% |
| Mar 31, 2025 | 20.92% |
| Dec 31, 2024 | 31.73% |
| Sep 30, 2024 | 27.86% |
| Jun 30, 2024 | 35.31% |
| Mar 31, 2024 | 29.79% |
| Dec 31, 2023 | 16.67% |
| Sep 30, 2023 | 22.29% |
| Jun 30, 2023 | 37.54% |
| Mar 31, 2023 | 34.41% |
| Dec 31, 2022 | 28.39% |
| Sep 30, 2022 | 37.42% |
| Jun 30, 2022 | 19.54% |
| Mar 31, 2022 | 35.35% |
| Dec 31, 2021 | 21.39% |
| Sep 30, 2021 | 25.90% |